BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17996243)

  • 1. Rational design of peptide ligand for affinity chromatography of tissue-type plasminogen activator by the combination of docking and molecular dynamics simulations.
    Liu FF; Dong XY; Wang T; Sun Y
    J Chromatogr A; 2007 Dec; 1175(2):249-58. PubMed ID: 17996243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of affinity peptide ligand by flexible docking simulation.
    Liu FF; Wang T; Dong XY; Sun Y
    J Chromatogr A; 2007 Mar; 1146(1):41-50. PubMed ID: 17298835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel biomimetic affinity ligands for human tissue plasminogen activator.
    Wu F; Yu J; Li R
    Biochem Biophys Res Commun; 2007 Apr; 355(3):673-8. PubMed ID: 17307143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homology modeling of tissue-type plasminogen activator K1 domain and studies on the interactions between kringles and lysine.
    Wang G; Liu S; Xu X; Huang P; Huang C
    Chin J Biotechnol; 1998; 14(1):17-24. PubMed ID: 9759541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and characterization of a t-PA mutant for use in ATTEMPTS: a drug delivery system for achieving targeted thrombolysis.
    Yang VC; Naik SS; Song H; Dombkowski AA; Crippen G; Liang JF
    J Control Release; 2005 Dec; 110(1):164-76. PubMed ID: 16260060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamic investigation of the interaction of supported affinity ligands with monoclonal antibodies.
    Zamolo L; Busini V; Moiani D; Moscatelli D; Cavallotti C
    Biotechnol Prog; 2008; 24(3):527-39. PubMed ID: 18452341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined docking, molecular dynamics simulations and spectroscopic studies for the rational design of a dipeptide ligand for affinity chromatography separation of human serum albumin.
    Aghaee E; Ghasemi JB; Manouchehri F; Balalaie S
    J Mol Model; 2014 Oct; 20(10):2446. PubMed ID: 25220335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking of balanol to dynamics snapshots of protein kinase A.
    Wong CF; Kua J; Zhang Y; Straatsma TP; McCammon JA
    Proteins; 2005 Dec; 61(4):850-8. PubMed ID: 16245317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid phase peptide synthesis on epoxy-bearing methacrylate monoliths.
    Vlakh E; Novikov A; Vlasov G; Tennikova T
    J Pept Sci; 2004 Dec; 10(12):719-30. PubMed ID: 15635624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of lead fullerene-based inhibitor bound to human immunodeficiency virus type 1 protease in solution from molecular dynamics simulations.
    Lee VS; Nimmanpipug P; Aruksakunwong O; Promsri S; Sompornpisut P; Hannongbua S
    J Mol Graph Model; 2007 Sep; 26(2):558-70. PubMed ID: 17468026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some chemical properties of tissue plasminogen activator purified from paranasal mucous membrane.
    Kosugi T; Nakamura M; Tsukayama T; Haraguchi S; Noda Y
    Rhinology; 1987 Jun; 25(2):129-32. PubMed ID: 3112919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression analysis and purification of human recombinant tissue type plasminogen activator (rt-PA) from transgenic tobacco plants.
    Nabiabad HS; Yaghoobi MM; Javaran MJ; Hosseinkhani S
    Prep Biochem Biotechnol; 2011; 41(2):175-86. PubMed ID: 21442553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and activity of tissue-type plasminogen activator mutant reteplase with deletion of PAI-1 binding sites].
    Zhu MC; Zhan Z; Wang YJ; Liu CG; Shi Y; Cai Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Sep; 21(5):565-9. PubMed ID: 16143058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining docking and molecular dynamic simulations in drug design.
    Alonso H; Bliznyuk AA; Gready JE
    Med Res Rev; 2006 Sep; 26(5):531-68. PubMed ID: 16758486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A computational study of the binding of propidium to the peripheral anionic site of human acetylcholinesterase.
    Cavalli A; Bottegoni G; Raco C; De Vivo M; Recanatini M
    J Med Chem; 2004 Jul; 47(16):3991-9. PubMed ID: 15267237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic mechanism of l,l-diaminopimelic acid with diaminopimelate epimerase by molecular docking simulations.
    Brunetti L; Galeazzi R; Orena M; Bottoni A
    J Mol Graph Model; 2008 Apr; 26(7):1082-90. PubMed ID: 18023379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulations of human LRH-1: the impact of ligand binding in a constitutively active nuclear receptor.
    Burendahl S; Treuter E; Nilsson L
    Biochemistry; 2008 May; 47(18):5205-15. PubMed ID: 18410128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental and theoretical investigation of effect of spacer arm and support matrix of synthetic affinity chromatographic materials for the purification of monoclonal antibodies.
    Zamolo L; Salvalaglio M; Cavallotti C; Galarza B; Sadler C; Williams S; Hofer S; Horak J; Lindner W
    J Phys Chem B; 2010 Jul; 114(29):9367-80. PubMed ID: 20590137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the interaction of GFG tripeptide with cesium perfluorooctanoate micelles by means of NMR spectroscopy and MD simulations.
    Pizzanelli S; Forte C; Monti S
    Langmuir; 2008 Jun; 24(11):5809-15. PubMed ID: 18452323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and high-yield purification of porcine heart tissue-type plasminogen activator by heparin-sepharose choromatography.
    Soeda S; Kakiki M; Shimeno H; Nagamatsu A
    Life Sci; 1986 Oct; 39(15):1317-24. PubMed ID: 3093793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.